Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have signs or symptoms of a condition called PTEN Hamartoma Tumor Syndrome (PHTS), AND you have a change (mutation) in the PTEN gene — this includes gene changes that are uncertain in meaning (called "variants of uncertain significance") as long as you also have clinical signs of the condition
- You are willing to take part in the study
Who may not be able to join:
- You do not have signs or symptoms of PHTS, do not have a PTEN gene mutation, and/or are not willing to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hande Kaymakcalan Celebiler, MD, Yale University
Phone: +905323768107
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Genotype-phenotype correlations of pediatric patients with PTEN Hamartoma Tumor Syndrome (PHTS) and creation of patient registry
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.